Tirzepatide (Pen)

The dual-agonist behind the strongest weight loss to date.

weight lossglp-1appetiteinjection pen

Pricing for this product is available to members. Create an account.

Tirzepatide is the compound behind Mounjaro and Zepbound, hitting both the GLP-1 and GIP receptors at once. That double action slows how fast your stomach empties, quietens appetite and improves how your body handles blood sugar, which is why it drives some of the strongest weight loss of any peptide yet. This pre-filled pen holds 30 mg and is titrated up slowly over several weeks. Like any GLP-1, expect some early nausea while your body settles in.

What it's used for

✓Dual GIP and GLP-1 agonist
✓Strong appetite control and weight loss
✓Improves blood-sugar handling
✓30 mg multidose pre-filled pen

In stockweight loss

Pairs with

New

Xenogenix Retatrutide pre-filled injection pen and box

64 mg · pre-filled penweight loss

Retatrutide (Pen)

The triple agonist outpacing everything before it.

Xenogenix Tirzepatide self-mix vial and bacteriostatic water

30 mg · self-mix vialweight loss

Tirzepatide (Vial)

The dual-agonist weight-loss peptide, as a self-mix vial.

Xenogenix Retatrutide self-mix vial and bacteriostatic water

32 mg · self-mix vialweight loss

Retatrutide (Vial)

The triple-agonist weight-loss peptide, as a self-mix vial.